Conmed (CNMD) Net Cash Flow (2010 - 2026)

Conmed (CNMD) has reported Net Cash Flow for 17 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow rose 177.74% year-over-year to $2.4 million; the trailing twelve-month figure through Jun 2026 stood at $4.3 million (changed 0.38% YoY), and the FY2025 full-year result was $13.9 million, up 382.42% from the prior year.
• Net Cash Flow advanced to $2.4 million in Q2 2026 per CNMD's latest filing, from -$5.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $29.6 million in Q2 2022 and bottomed at -$18.5 million in Q3 2022.
• Historically, Net Cash Flow has averaged $998388.9 across 5 years, with a median of $1.6 million in 2023.
• The widest YoY moves for Net Cash Flow: up 466.12% in 2024, down 421.96% in 2024.
• Over 5 years, Net Cash Flow stood at -$6.4 million in 2022, then retreated by 12.89% to -$7.2 million in 2023, then plunged by 62.91% to -$11.8 million in 2024, then soared by 115.75% to $1.9 million in 2025, then jumped by 30.91% to $2.4 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $2.4 million, -$5.0 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.